Yttrium-90 Therapy for Liver Metastases: A Comprehensive Guide

Overview

Yttrium-90 (Y-90) therapy is a targeted radiation treatment used primarily for liver metastases—cancer that has spread to the liver from other parts of the body, most commonly colorectal cancer. This therapy delivers high doses of radiation directly to liver tumors while minimizing damage to healthy tissue.

Liver metastases are common in advanced-stage cancers. According to the American Cancer Society, about 50% of people with colorectal cancer develop liver metastases. Y-90 therapy offers a localized treatment option for patients who may not be candidates for surgery or systemic chemotherapy.

Symptoms

Symptoms of liver metastases can vary depending on the size and location of the tumors. Common symptoms include:

• Abdominal pain or swelling – Discomfort in the upper right side of the abdomen due to liver enlargement.
• Jaundice – Yellowing of the skin and eyes caused by impaired liver function.
• Fatigue – Persistent tiredness due to the body’s response to cancer.
• Nausea or vomiting – Digestive issues resulting from liver dysfunction.
• Weight loss – Unintentional weight loss due to metabolic changes.
• Loss of appetite – Reduced desire to eat, often accompanied by early satiety.
• Fever or night sweats – Signs of inflammation or infection.

If you experience any of these symptoms, consult a healthcare provider for evaluation.

Causes and Risk Factors

Liver metastases occur when cancer cells from a primary tumor (e.g., colon, breast, lung) spread to the liver through the bloodstream or lymphatic system. Risk factors include:

• History of primary cancer – Especially colorectal, breast, or lung cancer.
• Advanced-stage cancer – Higher likelihood of metastasis.
• Weakened immune system – Reduced ability to fight cancer spread.
• Genetic predisposition – Certain genetic mutations increase metastasis risk.

According to the National Cancer Institute (NCI), liver metastases are most common in colorectal cancer patients, with up to 70% developing liver involvement at some point.

Diagnosis

Diagnosis involves imaging and sometimes biopsy to confirm liver metastases. Common diagnostic tools include:

• CT or MRI scans – Detailed images to locate and measure tumors.
• PET scan – Identifies metabolic activity in tumors.
• Liver biopsy – Tissue sample analysis to confirm cancer type.
• Blood tests – Liver function tests (e.g., ALT, AST) and tumor markers (e.g., CEA for colorectal cancer).

Once diagnosed, a multidisciplinary team (oncologists, radiologists, surgeons) determines if Y-90 therapy is appropriate.

Treatment Options

Y-90 therapy is a form of radioembolization, where tiny radioactive beads (microspheres) are injected into the liver’s blood supply. The process includes:

1. Mapping procedure – A preliminary angiogram to assess blood flow and plan bead delivery.
2. Y-90 infusion – Radioactive beads are injected via a catheter into the hepatic artery, targeting tumors.

Other treatment options may include:

• Surgery – Resection of liver tumors if they are few and localized.
• Chemotherapy – Systemic or regional (e.g., hepatic artery infusion).
• Ablation therapies – Radiofrequency or microwave ablation to destroy tumors.

Y-90 therapy is often used when surgery is not feasible or as a complementary treatment.

Living with Yttrium-90 Therapy for Liver Metastases

After Y-90 therapy, patients may experience fatigue, mild abdominal pain, or nausea. Tips for management include:

• Rest and hydration – Adequate fluids and sleep aid recovery.
• Pain management – Over-the-counter or prescribed medications as needed.
• Follow-up imaging – Regular scans to monitor treatment response.
• Nutritional support – A balanced diet to maintain strength and liver function.

Patients should avoid close contact with pregnant women or young children for a short period due to residual radiation.

Prevention

While liver metastases cannot always be prevented, early detection and treatment of primary cancers reduce risk. Strategies include:

• Regular cancer screenings – Colonoscopies, mammograms, or lung cancer screenings as recommended.
• Healthy lifestyle – Balanced diet, exercise, and avoiding smoking/alcohol.
• Genetic counseling – For those with a family history of cancer.

Complications

Untreated liver metastases can lead to:

• Liver failure – Severe impairment of liver function.
• Portal hypertension – Increased blood pressure in the liver’s veins.
• Spread to other organs – Further metastasis to lungs, bones, or brain.

Early intervention with Y-90 therapy can help control tumor growth and improve quality of life.

When to Seek Emergency Care

Sources: Mayo Clinic, National Cancer Institute, CDC.